Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Dave Singh and Claus Vogelmeier.
Dave Singh
Connection Strength
1.458
Claus Vogelmeier
  1. Erratum to: Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management. Adv Ther. 2017 03; 34(3):771.
    View in: PubMed
    Score: 0.706
  2. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021 01 01; 203(1):24-36.
    View in: PubMed
    Score: 0.230
  3. Pharmacological treatment of COPD: the devil is always in the detail. Eur Respir J. 2018 04; 51(4).
    View in: PubMed
    Score: 0.191
  4. Erratum to "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary" [Arch Bronconeumol. 2017;53:128-49]. Arch Bronconeumol. 2017 07; 53(7):411-412.
    View in: PubMed
    Score: 0.181
  5. Comparative effectiveness of triple therapy versus dual bronchodilation in COPD. ERJ Open Res. 2019 Jul; 5(3).
    View in: PubMed
    Score: 0.052
  6. Benralizumab for the Prevention of COPD Exacerbations. N Engl J Med. 2019 09 12; 381(11):1023-1034.
    View in: PubMed
    Score: 0.051
  7. Perception of symptoms and quality of life - comparison of patients' and physicians' views in the COPD MIRROR study. Int J Chron Obstruct Pulmon Dis. 2017; 12:2189-2196.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.